From: Positive correlation between hypertensive retinopathy and albuminuria in hypertensive adults
Subgroup | N | Albuminuria, N (%) | Â | Hypertensive retinopathy groups | p for interaction | ||
---|---|---|---|---|---|---|---|
Normal | Grade 1 | Grade 2 | Grade 3 | ||||
 | OR (95% CI) | OR (95% CI) | OR (95% CI) | ||||
Sex | Â | Â | Â | Â | Â | Â | 0.780 |
 Male | 1070 | 94 (8.8) | ref | 1.91(0.89,4.08) | 2.34(0.96,5.71) | 3.33(0.78,14.24) |  |
 Female | 1893 | 235 (12.4) | ref | 1.49(0.96,2.32) | 2.05(1.2,3.5) | 1.78(0.71,4.49) |  |
Age, years | Â | Â | Â | Â | Â | Â | 0.147 |
  < 65 | 1769 | 163 (9.2) | ref | 1.53(0.9,2.6) | 2.33(1.27,4.29) | 0.89(0.23,3.45) |  |
  ≥ 65 | 1178 | 164 (13.9) | ref | 1.69(0.98,2.91) | 1.59(0.78,3.24) | 4.1(1.52,11.06) |  |
BMI, kg/m2 | Â | Â | Â | Â | Â | Â | 0.391 |
  < 24 | 1042 | 105 (10.1) | ref | 1.1(0.58,2.07) | 2.26(1.07,4.8) | 1.29(0.29,5.63) |  |
  ≥ 24, < 28 | 1178 | 134 (11.4) | ref | 1.77(0.95,3.3) | 2.17(1.03,4.6) | 2.75(0.79,9.59) |  |
  ≥ 28 | 728 | 90 (12.4) | ref | 2.13(0.99,4.57) | 1.49(0.58,3.85) | 3.36(0.85,13.27) |  |
Treatment group | Â | Â | Â | Â | Â | Â | 0.184 |
 Enalapril | 1255 | 123 (9.8) | ref | 1.06(0.64,1.76) | 1.45(0.77,2.7) | 2.48(0.85,7.24) |  |
 Enalapril + folic acid | 1222 | 121 (9.9) | ref | 2.48(1.27,4.82) | 3.07(1.42,6.68) | 2.8(0.85,9.23) |  |
SBP, mmHg | Â | Â | Â | Â | Â | Â | 0.785 |
  < 140 | 1686 | 137 (8.1) | ref | 1.56(0.9,2.69) | 2.37(1.24,4.55) | 1.66(0.45,6.06) |  |
  ≥ 140 | 1246 | 189 (15.2) | ref | 1.63(0.96,2.77) | 1.81(0.95,3.45) | 2.54(0.94,6.83) |  |
TG, mmol/L | Â | Â | Â | Â | Â | Â | 0.014 |
  < 1.7 | 1722 | 158 (9.2) | ref | 1.06(0.65,1.72) | 1.28(0.68,2.39) | 2.7(1.09,6.73) |  |
  ≥ 1.7 | 1201 | 166 (13.8) | ref | 2.58(1.36,4.9) | 3.62(1.75,7.48) | 1.08(0.22,5.38) |  |
TCHO, mmol/L | Â | Â | Â | Â | Â | Â | 0.237 |
  < 5.2 | 1259 | 126 (10.0) | ref | 1.77(0.96,3.28) | 2.59(1.24,5.41) | 3.86(1.31,11.38) |  |
  ≥ 5.2 | 1642 | 195 (11.9) | ref | 1.43(0.88,2.32) | 1.7(0.94,3.06) | 1(0.31,3.22) |  |
FBG, mmol/L | Â | Â | Â | Â | Â | Â | 0.693 |
  < 7.0 | 2393 | 223 (9.3) | ref | 1.47(0.95,2.27) | 2.09(1.24,3.52) | 1.98(0.71,5.54) |  |
  ≥ 7.0 | 508 | 98 (19.3) | ref | 1.94(0.88,4.28) | 1.78(0.68,4.64) | 2.97(0.89,9.95) |  |
HCY, μmol/L |  |  |  |  |  |  | 0.947 |
  < 10 | 686 | 75 (10.9) | ref | 1.1(0.51,2.34) | 1.63(0.65,4.13) | 2.57(0.53,12.44) |  |
  ≥ 10, < 15 | 1554 | 165 (10.6) | ref | 1.61(0.97,2.68) | 1.99(1.06,3.73) | 1.76(0.62,5.01) |  |
  ≥ 15 | 678 | 82 (12.1) | ref | 2.24(0.89,5.66) | 2.54(0.88,7.37) | 4(0.63,25.19) |  |
Hyperuricemia | Â | Â | Â | Â | Â | Â | 0.528 |
 No | 2303 | 251 (10.9) | ref | 1.66(1.09,2.51) | 1.85(1.1,3.1) | 2.45(1.04,5.78) |  |
 Yes | 624 | 72 (11.5) | ref | 1.65(0.64,4.24) | 3.16(1.11,8.99) | 1.41(0.23,8.66) |  |
Smoking status | Â | Â | Â | Â | Â | Â | 0.217 |
 Never | 2094 | 245 (11.7) | ref | 1.39(0.91,2.13) | 1.77(1.05,2.99) | 1.58(0.63,3.95) |  |
 Former | 284 | 29 (10.2) | ref | 5.37(0.63,45.8) | 4.81(0.45,51.81) | 0(0,Inf) |  |
 Current | 569 | 55 (9.7) | ref | 1.84(0.68,4.96) | 3.17(1.04,9.67) | 5.7(1,32.68) |  |
Alcohol consumption | Â | Â | Â | Â | Â | Â | 0.861 |
 Never | 2089 | 242 (11.6) | ref | 1.58(1.02,2.45) | 2.01(1.18,3.41) | 1.94(0.8,4.68) |  |
 Former | 168 | 27 (16.1) | ref | 3.84(0.67,22.08) | 4.06(0.45,36.69) | 4.07(0.04,411.17) |  |
 Current | 575 | 52 (9) | ref | 1.15(0.46,2.84) | 2.12(0.74,6.09) | 2.84(0.48,16.98) |  |